Non-Invasive Brain Stimulation and Substance Use
Completed · Not applicable · Has a placebo group
Conditions studied: Substance Use Disorders
In brief
The will investigate the feasibility and effectiveness and initial efficacy of non-invasive transcranial alternating current stimulation (tACS) on distress tolerance and inhibitory control among treatment seeking substance users.
Key facts
- Study ID
- NCT03122587
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 38
- Starts
- 2017-05-15
- Expected to finish
- 2019-02-01
- Last updated by the study team
- 2020-03-06
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Current Diagnostic and Statistical Manual of Mental Disorders (DSM-V) Substance Use Disorder
- Current smoker
- Abstinent from all substances (except nicotine) for at least the past 2 weeks
You may not qualify if…
- Current use of antiepileptic drugs and/or benzodiazepines
- Less than 6 months since an electroconvulsive therapy (ECT) session
- Current DSM-V Psychotic Disorder
- Pregnancy and/or nursing
- Ongoing or history of traumatic brain injury (TBI), reoccurring seizures, stroke, or brain tumors
- Medical or neurological illness
- Brain devices and/or implants
Where it is running
- Southlight Healthcare — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.